Release 5.9.0: Saved Query Alerts, Query Details, Collection Sizes and more!

Saved Query Alerts.

Receive a notification email when new data is added for your saved queries.

Query Details Improvements.

View details of your joined query when navigating between cited/citing panes.

Collection Limit Increase.

Create collections of up to 50,000 Patents or Scholarly Works.

Use Of Cannadidiol In The Reduction Of Convulsive Seizure Frequency In Treatment-resistant Epilepsy

  • Published: Jul 30, 2014
  • Family: 35
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info:
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).


Claims

Information currently unavailable.

Inventors

Information currently unavailable.

CPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Jul 30, 2014
  • Application: Jun 17, 2014
    GB GB 201410771 A
  • Priority: Jun 17, 2014
    GB GB 201410771 A

Sign in to the Lens